Secondary prevention of coronary disease with lipid-lowering drugs.
D000328:Adult; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D004311:Double-Blind Method; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000517:prevention & control; D009525:Niacin / Q000627:therapeutic use; D011897:Random Allocation
D000960:Hypolipidemic Agents; D009525:Niacin; D002784:Cholesterol